• Intravesical p21 mRNA-LNP Therapy in Bladder Cancer

  2026-08-22

  This FASEB Journal study develops chemically modified p21 mRNA encapsulated in lipid nanoparticles for localized intravesical treatment of bladder cancer. The approach restored nuclear p21, suppressed tumor-associated cell-cycle activity, and reduced orthotopic tumor growth while limiting systemic distribution in mice.

• OTUD3–SLC7A11 Axis in Sunitinib Resistance

  2026-08-22

  The reference study identifies OTUD3-mediated stabilization of SLC7A11 as a mechanism that protects clear cell renal cell carcinoma from sunitinib-induced ferroptosis. Its findings connect deubiquitination, cystine utilization, glutathione-dependent redox control, lipid peroxidation, and therapeutic resistance, while suggesting that OTUD3 is a potential sensitization target.

• Paroxetine Mesylate: From SERT to CRC Assays

  2026-08-21

  Paroxetine Mesylate is more than a Selective serotonin reuptake inhibitor: it is a valuable probe for connecting SERT pharmacology with MET–ERBB3 signaling in colorectal cancer models. This article translates the key evidence into practical assay-design decisions while separating established findings from exploratory interpretation.

• Hoechst 33342/PI Double Staining Kit Workflow

  2026-08-20

  Build a rapid fluorescent apoptosis assay that separates chromatin condensation from loss of membrane integrity in one microscopy workflow. The kit is especially useful for testing treatment response, including syringin–sunitinib combinations in renal cell carcinoma models, while disciplined controls and image analysis improve interpretation.

• Methicillin Sodium Salt: From Mechanism to Translation

  2026-08-20

  Methicillin sodium salt is more than a legacy antibiotic reference: it is a mechanistically defined probe for PBP-dependent cell wall synthesis and the MSSA-to-MRSA resistance boundary. This article explains how to use it in susceptibility testing, gram-positive infection models, and translational decision-making, while placing its value alongside the phase 3 EAGLE-1 study of gepotidacin in gonorrhoea. The emphasis is on experimental architecture, resistance-aware interpretation, and the distinction between a useful benchmark and a clinically deployable therapy.

• LC-MS/MS Reveals Carbapenemase Resistance

  2026-08-19

  A 2025 study used LC-MS/MS metabolomics and supervised machine learning to distinguish carbapenemase-producing Enterobacterales from non-CPE isolates after only six hours of antibiotic-free growth. Its 21-metabolite signature and pathway-level findings support faster resistance detection while also highlighting the metabolic complexity of carbapenem resistance.

• Separating Arrest from Death in Cancer Assays

  2026-08-19

  Hannah Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. Its central contribution is a time-aware framework for distinguishing proliferative arrest from cell killing, improving interpretation of drug-response experiments and the evaluation of DNA repair-targeting agents.

• Standardized Whole-Blood Immunometabolism Assays

  2026-08-18

  Zhao and colleagues present a standardized ex vivo whole-blood stimulation protocol for measuring how metabolic interventions reshape cytokine responses to pattern-recognition receptor and microbial stimuli. The workflow preserves a physiologically complex blood environment while organizing collection, stimulation, controls, metabolic modulation, and cytokine quantification for reproducible cohort-scale studies.

• CerS6, Ceramide, and Stress-Induced Liver Injury

  2026-08-18

  Liu et al. identify CerS6-derived mitochondrial C16:0 ceramide as a mechanistic link between restraint stress, corticosterone signaling, and hepatocyte mitochondrial injury. By combining rat and hepatocyte models with mitochondrial lipid analysis and targeted perturbations, the study provides a framework for evaluating stress-responsive phosphorylation and sphingolipid pathways in liver research.

• Cy5-UTP for Spatial RNA Assay Design

  2026-08-17

  Cy5-UTP enables direct fluorescent RNA probe synthesis for FISH, arrays, and mechanistic studies of RNA localization. This guide explains how Cyanine 5-uridine triphosphate can translate stress-granule biology into better assay design without confusing probe labeling with endogenous RNA modification.

• Phase Separation in Plant Virus–Host Interactions

  2026-08-17

  Brown, Garrison, and May show that the Pea enation mosaic virus 2 movement protein p26 uses electrostatic phase separation to engage both proviral fibrillarin and antiviral G3BP compartments. Their integrated biochemical, cellular, and plant-virus experiments connect condensate formation with nucleolar trafficking, systemic movement, and stress-granule-mediated restriction of viral RNA.

• Cy5-UTP RNA Labeling: Workflow and Optimization

  2026-08-16

  Cy5-UTP enables direct, far-red fluorescent RNA probe synthesis for FISH, expression profiling, and nanoparticle tracking. This practical guide connects T7 in vitro transcription RNA labeling with assay design, quality control, and troubleshooting informed by recent RNA-delivery research.

• Apigenin: From HDAC Biology to Translational Strategy

  2026-08-15

  Apigenin is emerging as a research bridge between epigenetic oncology and network-guided neurodegeneration studies. This article examines its mechanistic rationale, preclinical evidence, practical assay design, translational limitations, and strategic value for researchers developing better-connected validation programs.

• HyperScript™ Reverse Transcriptase for qPCR

  2026-08-14

  HyperScript™ Reverse Transcriptase supports demanding RNA-to-cDNA workflows where secondary structure, low template abundance, or long transcripts limit conventional reverse transcription. This practical guide connects enzyme selection with exogenous M-MuLV quantification, qPCR controls, and troubleshooting decisions.

• Capsaicin: TRPV1 and KDM1A Research Workflow

  2026-08-14

  Capsaicin is a versatile research tool for connecting TRPV1 ion channel activation with pain, itch, and inflammation models, while also enabling mechanistic studies of reversible KDM1A/LSD1 inhibition. This workflow-oriented guide explains solvent handling, assay design, gastric cancer applications, sensory-neuron experiments, and troubleshooting strategies.

7997 records 1/534 page Next 12345 下5页 Last page